搜尋結果
US FDA expands use of Bristol's cell therapy to treat rare blood cancer
Reuters· 6 日前, opens new tab said on Thursday the U.S. FDA had allowed expanded use of its cell therapy for ...
Judges did not ‘rubberstamp’ fees in $2.7 bln Blue Cross deal, US Supreme Court told
Reuters· 6 日前A U.S. appeals court did not “rubberstamp” a $667 million fee award for the attorneys behind a ...
Clorox and these other stocks are on the verge of marking a death cross chart pattern
CNBC· 6 日前A small group of stocks is on the verge of forming a worrisome chart pattern known as a ...
This Week In Credit Card News: High Interest Rates Hurting Consumers And Companies
Forbes· 7 日前This amounts to the largest single increase in debt-related costs and the highest cumulative ...